Editorial – Medical marijuana

Editorial originally appeared in The Topeka Capital-Journal

It is extremely concerning to me that our local media is just blindly accepting the medical marijuana legislation instead of questioning very serious elements.

Why are we allowing the legislature to bypass the FDA for approving “medication?” All other medication’s have been required to go through the FDA approval processes

Why are we allowing the use of marijuana for illnesses or conditions that have zero or little research science behind them?

Why are we willing to accept an extremely high dose level of THC that has been clearly demonstrated to cause episodes of psychosis?

How are we going to deal with patients that want to smoke pot while they are hospitalized for other conditions. Will hospitals be required to carry marijuana?

Will malpractice lawsuits increase because of serious side effects from Marijuana recommendations?

Why are we not hearing about all of the negative experiences from other states that have succumbed to medical marijuana. There is tremendous evidence that allowing medical marijuana was a mistake

News media needs to be asking these questions and pushing back on a dangerous and potentially harmful legislative action.

If you don’t trust my opinion, I would be happy to connect you with a host of physicians from other states that have been dealing with this.

Eric Voth MD.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top